Morgan Stanley Call 120 ABL 21.06.../ DE000MB7GNW1 /
23/05/2024 11:43:47 | Chg.-0.004 | Bid16:39:22 | Ask16:39:22 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.018EUR | -18.18% | 0.022 Bid Size: 80,000 |
0.040 Ask Size: 80,000 |
ABBOTT LABS | 120.00 - | 21/06/2024 | Call |
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
02/10/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
06/09/2023
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region